Clemens Doppler

Biography

Dr Doppler is a Managing Partner at Heidelberg Capital Asset Management GmbH. Prior to joining Heidelberg Capital in 2008, he was a director at 3i since 2000 and has 10 years of international business experience in the pharma and biotech industries. He held senior position at Boehringer Mannheim (now Roche) and was in the management team of Swiss Biotech company ANAWA Laboratories AG, which was successfully sold in 1997 to Phoenix International Life Science (now MDS Inc.). As well as serving on various boards, Dr Doppler is a member of the German biotech analyst association DVFA. He is also a fellow of the German Cancer Research Centre. Dr Doppler holds degrees in marketing and economics and a MSc and Ph.D. in molecular biology, chemistry and microbiology from the University of Heidelberg.

Research Interest

Medicine and Pharmaceutical